BioCentury
ARTICLE | Company News

Aphton cancer news

May 29, 2006 7:00 AM UTC

APHT filed for Chapter 11 bankruptcy. The company discontinued lead compound Insegia (G17DT) last May after it missed the primary endpoint of overall survival in a Phase III trial to treat pancreatic ...